881.60 3.40 (0.39%)

46.21% Fall from 52W High

524.7K NSE+BSE Volume

NSE 19 Jun, 2025 3:31 PM (IST)

US FDA Observation
Natco Pharma gets Form 486 with one observation from the US FDA for its API facility in Hyderabad See details


Natco Pharma Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for NATCOPHARM, BSE:524816 Natco Pharma Ltd.

541 Votes:
Buy 83.18%
Sell 7.39%
Hold 9.43%
BUY
SELL
HOLD